328 related articles for article (PubMed ID: 36233409)
1. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future.
Komarnicki P; Musiałkiewicz J; Stańska A; Maciejewski A; Gut P; Mastorakos G; Ruchała M
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233409
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
Modlin IM; Bodei L; Kidd M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844
[TBL] [Abstract][Full Text] [Related]
3. Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic use.
Tsoli M; Koumarianou A; Angelousi A; Kaltsas G
Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101785. PubMed ID: 37336711
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review).
Ciobanu OA; Martin S; Fica S
Exp Ther Med; 2021 Dec; 22(6):1479. PubMed ID: 34765020
[TBL] [Abstract][Full Text] [Related]
5. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract][Full Text] [Related]
6. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide.
Bevere M; Masetto F; Carazzolo ME; Bettega A; Gkountakos A; Scarpa A; Simbolo M
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685358
[TBL] [Abstract][Full Text] [Related]
7. Tumor markers in neuroendocrine tumors.
Eriksson B; Oberg K; Stridsberg M
Digestion; 2000; 62 Suppl 1():33-8. PubMed ID: 10940685
[TBL] [Abstract][Full Text] [Related]
8. Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study.
van Treijen MJC; Korse CM; van Leeuwaarde RS; Saveur LJ; Vriens MR; Verbeek WHM; Tesselaar MET; Valk GD
Front Endocrinol (Lausanne); 2018; 9():740. PubMed ID: 30564197
[No Abstract] [Full Text] [Related]
9. Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.
Oberg K
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):109-12. PubMed ID: 22584714
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
[TBL] [Abstract][Full Text] [Related]
11. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.
Oberg K; Krenning E; Sundin A; Bodei L; Kidd M; Tesselaar M; Ambrosini V; Baum RP; Kulke M; Pavel M; Cwikla J; Drozdov I; Falconi M; Fazio N; Frilling A; Jensen R; Koopmans K; Korse T; Kwekkeboom D; Maecke H; Paganelli G; Salazar R; Severi S; Strosberg J; Prasad V; Scarpa A; Grossman A; Walenkamp A; Cives M; Virgolini I; Kjaer A; Modlin IM
Endocr Connect; 2016 Sep; 5(5):174-87. PubMed ID: 27582247
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of neuroendocrine tumors.
d'Herbomez M; Coppin L; Bauters C; Rouaix-Emery N; Carnaille B; Do Cao C
Ann Biol Clin (Paris); 2016 Dec; 74(6):669-679. PubMed ID: 27758762
[TBL] [Abstract][Full Text] [Related]
13. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive Review.
Kalligeros M; Diamantopoulos L; Toumpanakis C
Biology (Basel); 2021 Sep; 10(10):. PubMed ID: 34681049
[TBL] [Abstract][Full Text] [Related]
15. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.
Mariën L; Islam O; Chhajlani S; Lybaert W; Peeters M; Van Camp G; Op de Beeck K; Vandamme T
Curr Treat Options Oncol; 2023 Dec; 24(12):1833-1851. PubMed ID: 37989978
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot.
Fernandez CJ; Agarwal M; Pottakkat B; Haroon NN; George AS; Pappachan JM
World J Gastrointest Surg; 2021 Mar; 13(3):231-255. PubMed ID: 33796213
[TBL] [Abstract][Full Text] [Related]
18. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry of neuroendocrine tumours.
de Herder WW
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumor biomarkers: current status and perspectives.
Modlin IM; Oberg K; Taylor A; Drozdov I; Bodei L; Kidd M
Neuroendocrinology; 2014; 100(4):265-77. PubMed ID: 25300695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]